Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine

This publication has 31 references indexed in Scilit:

• Nonstimulant treatment of adult attention-deficit/hyperactivity disorder
  Psychiatric Clinics of North America, 2004
• Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder
  Clinical Therapeutics, 2003
• SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task
  European Journal of Pharmacology, 2003
• The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions
  British Journal of Pharmacology, 2003
• Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder
  Neuropsychopharmacology, 2002
• Effects of Typical and Atypical Antipsychotics and Receptor Selective Compounds on Acetylcholine Efflux in the Hippocampus of the Rat
  Neuropsychopharmacology, 2002
• Atypical, but Not Typical, Antipsychotic Drugs Increase Cortical Acetylcholine Release without an Effect in the Nucleus Accumbens or Striatum
  Neuropsychopharmacology, 2002
• CENTRAL CHOLINERGIC SYSTEMS AND COGNITION
  Annual Review of Psychology, 1997
• Facilitation of glutamate receptors enhances memory.
  Proceedings of the National Academy of Sciences, 1994
• Basal acetylcholine release in freely moving rats detected by on-line trans-striatal dialysis: Pharmacological aspects
  Life Sciences, 1988